Meta-Analysis of Gene Expressions in Testicular Germ Cell Tumor Histologies

被引:10
|
作者
von Eyben, Finn Edler [1 ]
Parraga-Alava, Jorge [2 ,3 ]
机构
[1] Ctr Tobacco Control Res, DK-5230 Odense M, Denmark
[2] Univ Tecn Manabi, Fac Ciencias Informat, Portoviejo 130105, Ecuador
[3] Univ Santiago Chile, Dept Ingn Informat, Santiago 9170020, Chile
关键词
biomarkers; genes for pluripotency; meta-analysis; oncogenes; pathogenesis; RNA expression; testicular neoplasms; tumor suppressor genes; CARCINOMA IN-SITU; EPIGENETIC FEATURES; DOWN-REGULATION; STEM-CELLS; DIFFERENTIATION; TESTIS; METHYLATION; NEOPLASIA; PATHOGENESIS; TRANSITION;
D O I
10.3390/ijms21124487
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is no consensus as to how a precursor lesion, germ cell neoplasia in situ (GCNIS), develops into the histologic types of testicular germ cell tumor type II (TGCT). The present meta-analysis examined RNA expressions of 24 candidate genes in three datasets. They included 203 samples of normal testis (NT) and histologic types of TGCT. The Fisher's test for combinedpvalues was used for meta-analysis of the RNA expressions in the three datasets. The histologic types differed in RNA expression ofPRAME, KIT, SOX17, NANOG, KLF4, POU5F1, RB1, DNMT3B, andLIN28A(p< 0.01). The histologic types had concordant differences in RNA expression of the genes in the three datasets. Eight genes had overlap with a high RNA expression in at least two histologic types. In contrast, only seminoma (SE) had a high RNA expression ofKLF4and only embryonal carcinoma (EC) had a high RNA expression ofDNMT3B. In conclusion, the meta-analysis showed that the development of the histologic types of TGCT was driven by changes in RNA expression of candidate genes. According to the RNA expressions of the ten genes, TGCT develops from NT over GCNIS, SE, EC, to the differentiated types of TGCT.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 50 条
  • [31] Endobronchial metastasis of testicular germ cell tumor
    Turan, Demet
    Ozgul, Mehmet Akif
    Kirkil, Gamze
    Cetinkaya, Erdogan
    EURASIAN JOURNAL OF PULMONOLOGY, 2018, 20 (03) : 171 - 173
  • [32] Mediastinal Germ Cell Tumor with Testicular Microlithiasis
    Mulla, Nasser
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [33] Testicular germ cell tumor pathology reporting
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 509 - 510
  • [34] Testicular germ cell tumor: a comprehensive review
    Aalia Batool
    Najmeh Karimi
    Xiang-Nan Wu
    Su-Ren Chen
    Yi-Xun Liu
    Cellular and Molecular Life Sciences, 2019, 76 : 1713 - 1727
  • [35] Testicular germ cell tumor: a comprehensive review
    Batool, Aalia
    Karimi, Najmeh
    Wu, Xiang-Nan
    Chen, Su-Ren
    Liu, Yi-Xun
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (09) : 1713 - 1727
  • [36] Unusual metastasis of a testicular germ cell tumor
    Borda, A.
    Preda, O.
    Loghin, A.
    Decaussin-Petrucci, M.
    Ragage, F.
    Berger, N.
    VIRCHOWS ARCHIV, 2009, 455 : 237 - 237
  • [37] Bilateral testicular tumors. Combination of a testicular germ cell tumor with a contralateral benign non-germ cell tumor
    Neubauer, S
    Heidenreich, A
    UROLOGE-AUSGABE A, 1999, 38 (03): : 282 - 284
  • [38] Association Between BAK1 Gene rs210138 Polymorphisms and Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis
    Qin, Jiaxuan
    Yang, Yufeng
    Zhuang, Xuan
    Xing, Jinchun
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [39] Skin cancer risk among testicular germ-cell cancer survivors: a systematic review and meta-analysis
    Reiter, O.
    Voss, V. B.
    Fluss, R.
    Boyce, L. M.
    DeFazio, J. L.
    Halpern, A. C.
    Marghoob, A. A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : 1025 - 1033
  • [40] Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors
    Kempkensteffen, Carsten
    Christoph, Frank
    Weikert, Steffen
    Krause, Hans
    Koellermann, Jens
    Schostak, Martin
    Miller, Kurt
    Schrader, Mark
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (12) : 765 - 770